Awarded contract

NP48925b Hereditary Angioedema Branded Medicines (Berinert)

Details

Supplier(s)
CSL Behring
Value
GBP 4,733,292
Topic
Pharmaceutical products
Published
4 April 2025

Tender description

Supply of C1-esterase inhibitor human powder and solvent for solution for injection vials (various strengths) (Berinert®) to NHS Scotland. Lot 1: The Framework Agreement is for the supply of hereditary angioedema (HAE) branded medicines to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.

Timeline

  1. Completed: Award published4 April 2025
    Current notice
  2. Completed: Award date4 April 2025

About the buyer

NHS National Services Scotland is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 33600000 · Pharmaceutical products

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

6 similar open tenders

See more open tenders related to NP48925b Hereditary Angioedema Branded Medicines (Berinert).

Explore all open tenders

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.